FMC Corp (FMC):企業の財務・戦略的SWOT分析

◆英語タイトル:FMC Corp (FMC) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDCH29372FSA
◆発行会社(調査会社):GlobalData
◆発行日:2021年3月
◆ページ数:57
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:Chemicals
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD250 ⇒換算¥32,750見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥49,125見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

FMC Corp (FMC) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

FMC Corp (FMC) is a chemical company that serves the agricultural market. It develops, markets and sells insecticides, herbicides and fungicides and manufactures lithium. These products are used in agriculture to enhance crop yield and quality by controlling a broad spectrum of insects, weeds and diseases; and in non-agricultural markets for pest control. The company’s pesticide portfolio includes insecticides, herbicides and fungicides. Insecticides are used to control a wide spectrum of pests and the herbicide portfolio targets a large variety of difficult-to-control weeds. It also invests in a plant health program that includes biological crop protection products, seed treatments and micro-nutrients. It has facilities in North America, Europe, Latin America, Middle East and Africa, and Asia. FMC is headquartered in Philadelphia, Pennsylvania, the US.

FMC Corp Key Recent Developments

Feb 09,2021: FMC reports fourth quarter results in-line with pre-release and 2021 guidance reflects strong growth
Feb 09,2021: FMC announces Pierre Brondeau to transition from Executive Chairman
Feb 03,2021: FMC Corporation Announces Date of 2021 Annual Meeting of Stockholders
Jan 19,2021: FMC updates fourth quarter 2020 outlook
Aug 04,2020: FMC raises Full-Year 2020 guidance following solid second quarter result

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
FMC Corp – Key Facts
FMC Corp – Key Employees
FMC Corp – Key Employee Biographies
FMC Corp – Major Products and Services
FMC Corp – History
FMC Corp – Company Statement
FMC Corp – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
FMC Corp – Business Description
Business Segment: FMC Agricultural Solutions
Overview
Performance
Key Stats
Geographical Segment: Asia
Performance
Geographical Segment: Europe, Middle East, and Africa
Performance
Geographical Segment: Latin America
Performance
Geographical Segment: North America
Performance
R&D Overview
FMC Corp – Corporate Strategy
FMC Corp – SWOT Analysis
SWOT Analysis – Overview
FMC Corp – Strengths
FMC Corp – Weaknesses
FMC Corp – Opportunities
FMC Corp – Threats
FMC Corp – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Company’s Petrochemicals Financial Deals and Alliances
FMC Corp, Petrochemicals, Deals By Year, 2015 to YTD 2021
FMC Corp, Petrochemicals, Deals By Type, 2015 to YTD 2021
FMC Corp, Recent Deals Summary
Section 5 – Company’s Recent Developments
Feb 09, 2021: FMC reports fourth quarter results in-line with pre-release and 2021 guidance reflects strong growth
Feb 09, 2021: FMC announces Pierre Brondeau to transition from Executive Chairman
Feb 03, 2021: FMC Corporation Announces Date of 2021 Annual Meeting of Stockholders
Jan 19, 2021: FMC updates fourth quarter 2020 outlook
Aug 04, 2020: FMC raises Full-Year 2020 guidance following solid second quarter result
Jul 13, 2020: FMC announces election of John Davidson to board of directors
Apr 22, 2020: FMC provides update on liquidity and confirms strong first quarter performance
Feb 05, 2020: FMC Corporation delivers strong fourth quarter and full-year results
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
FMC Corp, Key Facts
FMC Corp, Key Employees
FMC Corp, Key Employee Biographies
FMC Corp, Major Products and Services
FMC Corp, History
FMC Corp, Other Locations
FMC Corp, Subsidiaries
FMC Corp, Key Competitors
FMC Corp, Ratios based on current share price
FMC Corp, Annual Ratios
FMC Corp, Annual Ratios (Cont...1)
FMC Corp, Annual Ratios (Cont...2)
FMC Corp, Interim Ratios
FMC Corp, Petrochemicals, Deals By Year, 2015 to YTD 2021
FMC Corp, Petrochemicals, Deals By Type, 2015 to YTD 2021
FMC Corp, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

★海外企業調査レポート[FMC Corp (FMC):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Lukoil Oil Co (LKOH):企業の財務・戦略的SWOT分析
    Lukoil Oil Co (LKOH) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Trafigura Group Pte Ltd:企業の戦略的SWOT分析
    Trafigura Group Pte Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products an …
  • SP Transmission plc:企業の戦略的SWOT分析
    SP Transmission plc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and se …
  • View Inc:電力:M&Aディール及び事業提携情報
    Summary View Inc (View), formerly Soladigm, Inc. is a clean technology company that offers smart glass systems. The company’s View Dynamic Glass controls light and heat entering the building. View Dynamic Glass uses intelligent engine that adapts to the environment, responds to users’ preferences an …
  • Capcom Co. Ltd. (9697):企業の財務・戦略的SWOT分析
    Capcom Co. Ltd. (9697) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Aprea AB-製薬・医療分野:企業M&A・提携分析
    Summary Aprea AB (Aprea) discovers and develops novel anticancer compounds targeting the tumor suppressor protein p53. The company’s lead drug candidate includes APR-246, an anti-cancer compound that targets and reactivates the tumor suppressor protein p53, inducing programmed cell death in many hum …
  • Epic Systems Corp:企業の戦略的SWOT分析
    Epic Systems Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and serv …
  • Ws Atkins Ltd:企業の戦略・SWOT・財務分析
    Ws Atkins Ltd - Strategy, SWOT and Corporate Finance Report Summary Ws Atkins Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • LOT Polish Airlines SA:企業の戦略・SWOT・財務情報
    LOT Polish Airlines SA - Strategy, SWOT and Corporate Finance Report Summary LOT Polish Airlines SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • US WorldMeds LLC:製薬・医療:M&Aディール及び事業提携情報
    Summary US WorldMeds LLC (US WorldMeds) is a specialty pharmaceutical company that develops, licenses and markets healthcare products to improve lives of patients with challenging conditions and unmet medical needs. The company’s products comprise apokyn, myobloc and revonto. Its apokyn is used for …
  • PharmaEssentia Corp (6446)-製薬・医療分野:企業M&A・提携分析
    Summary PharmaEssentia Corp (PharmaEssentia) is a research and development company that develops therapeutic products for the treatment of human diseases. The company’s pipeline product include P1101, a new generation PEG-Interferon-alpha-2b which is developed using PEGylation technology platform. I …
  • Goodwin Biotechnology Inc-製薬・医療分野:企業M&A・提携分析
    Summary Goodwin Biotechnology Inc (GBI), a subsidiary of Wallace Pharmaceuticals Pvt Ltd is a healthcare company that develops and manufactures vaccines, monoclonal antibodies, recombinant proteins and bioconjugates. The company offers cell culture, purification, bioconjugation, biosimilars, aseptic …
  • Calmare Therapeutics Inc (CTTC):企業の財務・戦略的SWOT分析
    Summary Calmare Therapeutics Inc (CTI) is a bio therapeutic company that offers pain mitigation and wound care technologies. The company provides non-pharmacological, non-addictive and non-invasive solution for chronic neuropathic pain and wound care affliction patients. It offers Calmare, a pain th …
  • Pharmstandard:企業の戦略的SWOT分析
    Pharmstandard - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services …
  • PetroEnergy Resources Corp (PERC):企業の財務・戦略的SWOT分析
    Summary PetroEnergy Resources Corp (PERC) is a diversified company that offers oilfield and energy services. The company’s services include upstream oil and gas exploration and development, power generation, and renewable energy development services, among others. It undertakes renewable energy proj …
  • Schnell Biopharmaceuticals Inc (003060)-製薬・医療分野:企業M&A・提携分析
    Summary Schnell Biopharmaceuticals Inc (Schnell), formerly Korea Schnell Pharma Co., Ltd. is a healthcare company that offers agents and antibiotics. The company provides pharmaceutical products including amino acid infusion agents and antibiotics. Its products portfolio includes antibiotics, infusi …
  • Virtus Investment Partners, Inc.:企業の戦略・SWOT・財務分析
    Virtus Investment Partners, Inc. - Strategy, SWOT and Corporate Finance Report Summary Virtus Investment Partners, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • Stanford University:企業のM&A・事業提携・投資動向
    Stanford University - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Stanford University Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), …
  • Agfa-Gevaert N.V.:企業の戦略・SWOT・財務情報
    Agfa-Gevaert N.V. - Strategy, SWOT and Corporate Finance Report Summary Agfa-Gevaert N.V. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Innopharmax Inc (4172):製薬・医療:M&Aディール及び事業提携情報
    Summary Innopharmax Inc (InnoPharmax), a subsidiary of Synmosa Biopharma Corp is a pharmaceutical company that develops and commercializes products for the treatment of oncology and specialty. The company provides anti-infection agents, oncology agents, contrast agents, immunological agents and drug …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆